Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.

Ye X, Jiang F, Li Y, Mu J, Si L, Wang X, Ning S, Li Z

DOI: 10.1111/cas.12426
Published: 2014 Jul
Container: Cancer science
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/cas.12426,
  title = {Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.},
  author = {Ye X and Jiang F and Li Y and Mu J and Si L and Wang X and Ning S and Li Z},
  year = {2014},
  journal = {Cancer science},
  doi = {10.1111/cas.12426},
  url = {https://doi.org/10.1111/cas.12426}
}

RIS

TY  - JOUR
TI  - Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.
AU  - Ye X
AU  - Jiang F
AU  - Li Y
AU  - Mu J
AU  - Si L
AU  - Wang X
AU  - Ning S
AU  - Li Z
PY  - 2014
JO  - Cancer science
DO  - 10.1111/cas.12426
UR  - https://doi.org/10.1111/cas.12426
ER  -

APA

X, Y., F, J., Y, L., J, M., L, S., X, W., S, N., & Z, L. (2014). Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.. Cancer science. https://doi.org/10.1111/cas.12426

Source records

pubmed · retrieved 2026-09-24T20:39:52.501Z